Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 25Uterine Cervical Dysplasia 13Melanoma 10Carcinoma, Basal Cell 10Glioma 6Glioblastoma 6Breast Neoplasms 5Uterine Cervical Neoplasms 4Neoplasm Metastasis 4Condylomata Acuminata 4Precancerous Conditions 3Papillomavirus Infections 3Keratosis 3Hutchinson's Melanotic Freckle 3Vulvar Neoplasms 2Urinary Bladder Neoplasms 2Squamous Intraepithelial Lesions 2Non-Muscle Invasive Bladder Neoplasms 2Neoplasms 2Hemangioma, Capillary 2HIV Infections 2Ependymoma 2Colorectal Neoplasms 2Brain Neoplasms 2Astrocytoma 2Warts 1Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1Virus Diseases 1Vaginal Neoplasms 1Stomach Neoplasms 1

Interventions

methyl 5-aminolevulinate 3Photochemotherapy 2SR-T100 1Myelin and Lymphocyte-Associated Proteolipid Proteins 1Microphysiological Systems 1Lidocaine, Prilocaine Drug Combination 1Lidocaine 1Laser Therapy 1Imiquimod 1Fluorouracil 1Epinephrine 1Cryotherapy 1Anesthesia, Local 13-ingenyl angelate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Bowen's Disease × Imiquimod × Clear all
NCT00384124 2008-03-26

Topical Imiquimod for Bowen's Disease of the Head and Neck

Brooke Army Medical Center

Phase 2/3 Unknown
50 enrolled

Bowen's Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡